Clinical response in patients with breast tumours treated with postmastectomy conformal radiotherapy at the National Institute of Cancerology, Colombia
Keywords:
Breast Neoplasms, Radiotherapy, MastectomyAbstract
Introduction: Breast cancer is the world’s leading cause of cancer, with 1,671,149 new cases and 521,907 deaths each year. Adjuvant radiotherapy in patients with T3-T4 tumours or with positive lymph nodes improves locoregional control and overall survival. There is a gap regarding the oncological outcomes and the toxicity derived from the treatments with new radiotherapy techniques used in our Institution since 2010.
Methods: A retrospective, descriptive, historical cohort study was conducted on 82 patients with a diagnosis of locally advanced breast cancer treated with post-mastectomy conformational radiotherapy in the Instituto Nacional de Cancerología, between 1 January 2010 and 31 December 2011.
Results: A total of 82 consecutive patients were included in the analysis. At 6 years of follow-up 87.8% (n = 72) were still alive, with 3 losses in follow-up. There was a relapse in 30%, and of these 76% were systemic, 12% regional, and 12% regional and systemic. Complications related to radiotherapy were present in 16% of patients.
Conclusion: The outcomes of multimodal management of locally advanced breast cancer are similar to those reported by clinical trials. In future studies it will be necessary to evaluate factors associated with regional relapse in this institution.
Author Biographies
Eduardo Guerrero, Instituto Nacional de Cancerología
Grupo área de Oncología Radioterápica y Física Médica, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Holman Ballesteros, Universidad Militar Nueva Granada
Grupo área de Oncología Radioterápica y Física Médica, Instituto Nacional de Cancerología, Universidad Militar Nueva Granada, Bogotá D. C., Colombia
Luis Felipe Torres, Instituto Nacional de Cancerología
Grupo área de Oncología Radioterápica y Física Médica, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
References
Globocan 2012 - Home 2018 [Available from: http://globocan.iarc.fr/Default.aspx.
Fisher B, Wolmark N, Redmond C, Deutsch M, Fisher ER. Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer. 1981;48:1863-72.
https://doi.org/10.1002/1097-0142(19811015)48:8<1863::AID-CNCR2820480825>3.0.CO;2-U
Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of nodepositive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol. 2003;21:1431-9.
https://doi.org/10.1200/JCO.2003.09.081
Bear HD, Anderson S, Brown A, Smith R, Mamounas EP, Fisher B, et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2003;21:4165-74.
https://doi.org/10.1200/JCO.2003.12.005
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687-717.
https://doi.org/10.1016/S0140-6736(05)66544-0
McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127-35.
https://doi.org/10.1016/S0140-6736(14)60488-8
Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949-55.
https://doi.org/10.1056/NEJM199710023371401
Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk post- menopausal breast-cancer patients given adjuvan t tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641-8.
https://doi.org/10.1016/S0140-6736(98)09201-0
Wang Q, Jie W, Liang Z, Wu H, Cheng J. Postmastectomy intensity modulation radiated therapy of chest wall and regional nodes: Retrospective analysis of the performance and complications up for 5 years. Medicine (Baltimore). 2017;96:e7956.
https://doi.org/10.1097/MD.0000000000007956
Cavey ML, Bayouth JE, Endres EJ, Pena JM, Colman M, Hatch S. Dosimetric comparison of conventional and forward-planned intensity-modulated techniques for comprehensive locoregional irradiation of post-mastectomy left breast cancers. Med Dosim. 2005;30:107-16.
https://doi.org/10.1016/j.meddos.2005.02.002
Lester SC, Bose S, Chen YY, Connolly JL, Baca ME, Fitzgibbons PL, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med. 2009;133:1515-38.
Li XA, Tai A, Arthur DW, Buchholz TA, MacDonald S, Marks LB, et al. Variability of target and normal structure delineation for breast-cancer radiotherapy: an RTOG multi-institutional and multi-observer study. Int J Radiat Oncol Biol Phys. 2009;73:944-51.
Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues. Int J Radiat Oncol Biol Phys. 2010;76:S3-9.
https://doi.org/10.1016/j.ijrobp.2009.09.040
Jagsi R. Postmastectomy radiation therapy: an overview for the practicing surgeon. ISRN Surg. 2013;2013:212979.
https://doi.org/10.1155/2013/212979
Nakajima N, Oguchi M, Kumai Y, Yoshida M, Inoda H, Yoshioka Y, et al. Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemothe- rapy followed by surgery and postmastectomy radiation therapy in the modern treatment era. Adv Radiat Oncol. 2018;3:271-9.
https://doi.org/10.1016/j.adro.2018.04.006
Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Loco-regional recurrence after mastectomy in high-risk breast cancer-risk and prognosis, An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol. 2006;79:147-55.
https://doi.org/10.1016/j.radonc.2006.04.006
Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicu- lar irradiation in breast cancer. N Engl J Med. 2015;373:317-27.
https://doi.org/10.1056/NEJMoa1415369
Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, et al. Postmastectomy Radiotherapy: An American Society of Clinical Oncology. American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. J Clin Oncol. 2016.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Todos los derechos reservados.
